Home › Funds › CAUSEWAY CAPITAL MANAGEMENT LLC › BIIB

CAUSEWAY CAPITAL MANAGEMENT LLC position in BIIB

BIOGEN INC · Health Care

CAUSEWAY CAPITAL MANAGEMENT LLC reported holding 278,283 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$60.1M, representing 0.65% of its reported portfolio and ranking #30 among its reported holdings. CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed BIIB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)278.28K sh
Reported value held$60.13M
Portfolio Weight0.65%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAUSEWAY CAPITAL MANAGEMENT LLC's BIIB position evolved

CAUSEWAY CAPITAL MANAGEMENT LLC first disclosed a stake in BIIB in Q4 2024 at 281,702 shares (US$43.1M). The position peaked in Q4 2025 at 521,101 shares, worth US$91.7M. Across 7 filings, CAUSEWAY CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 278,283 shares valued at US$60.1M — a reduction of -2,500 shares quarter over quarter.. Notable position changes include a 54% increase in Q1 2025 (shares fell 8% over the following quarter), a 46% trim in Q1 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 281.70K $43.08M New
Q1 2025 433.52K $59.32M Add
Q2 2025 493.36K $61.96M Add
Q3 2025 567.52K $79.50M Add
Q4 2025 521.10K $91.71M Reduce
Q1 2026 280.78K $51.48M Reduce
Q2 2026 278.28K $60.13M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has CAUSEWAY CAPITAL MANAGEMENT LLC held BIIB?

CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed BIIB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is CAUSEWAY CAPITAL MANAGEMENT LLC's current position in BIIB?

As of Q2 2026, CAUSEWAY CAPITAL MANAGEMENT LLC holds 278.28K shares of BIIB (BIOGEN INC), valued at $60.13M, representing 0.65% of its reported portfolio and ranking #30.

Has CAUSEWAY CAPITAL MANAGEMENT LLC been buying or selling BIIB?

In the latest 13F filing (Q2 2026), CAUSEWAY CAPITAL MANAGEMENT LLC reduced its position in BIIB. The position peaked in Q4 2025 at 521.10K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.